COVID has increased the focus on pets, particularly dogs
CP1 has products based on the latest “drug” technologies that will have your prized possession doing cartwheels on the lounge room floor
CP1 is suffering from a lack of market exposure
it’s a great tight run ship that needs a collaboration to help put it on the investors radar
A company within this space is looking for a catalyst to jump start its own operation and wants in - to dovetail CP1 into their own business before it enters a serious growth phase in its own right
if the deal is well structured CP1 will enter lift off dept.
CP1 Price at posting:
12.5¢ Sentiment: Buy Disclosure: Held
